However, further study is needed to understand the underlying etiology of how Cu controls the CNS immune responses, especially its function in the clearance of pathological hallmarks of AD, such as β-amyloid and tau, which may provide a new drug target for AD. The gene discussed is MAPT; the disease is Alzheimer disease.